日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer

ESR1突变转移性乳腺癌中与依拉司特疗效相关的临床和基因组因素

Lloyd, Maxwell R; Weipert, Caroline M; Ali, Azka; Solomon, Sheila R; Saha, Jayati; Lipsyc-Sharf, Marla D; Hamilton, Erika P; Kalinsky, Kevin; Brufsky, Adam M; Bardia, Aditya; Zhang, Nicole; Wander, Seth A

Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer.

在癌症实验模型中,通过定制化学诱变诱导错配修复缺陷基因型。

Rousseau Benoit, Patel Mitesh, Artz Oliver, Vlachos Georgios, Patel Shrey, Hayatt Omar, Argilés Guillem, Foote Michael B, Luo Lingqi, Shah Rachna, Mehta Shub, Rangavajhula Karthik, Stewart Caitlin M, Gerber Drew, Bhattacharya Rohini, Stephens Dennis, Mieles David, Randrian Violaine, Abdelfattah Somer, Zhang Lin, Membreno-Berganza Nathalie, Lamendola-Essel Michelle F, Piastra-Facon Florence, Vidal Joana, Johannet Paul, Lu Steve, White James R, Maron Steven B, Barlas Afsar, Weipert Caroline M, Rosiek Eric, Zhang Taotao, He Bing, Monette Sebastien, Qu Rui, Fidele Deborah, Bowker Sydney, Kahn Alec, Vitiello Pietro Paolo, Germano Giovanni, Bardelli Alberto, Mandal Rajarsi, Ma Xiaoxiao, Chan Tim A, Lu Sydney, Cercek Andrea, Abdel-Wahab Omar, de Stanchina Elisa, Segal Neil H, Diaz Luis A Jr

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.

从临床到实验室的转化分析:激素受体阳性转移性乳腺癌中 NF1 改变和 CDK4/6 抑制剂耐药性

Lloyd Maxwell R, Chica-Parrado Rosario, Weipert Caroline M, Knepper Todd C, Podany Emily L, Napolitano Fabiana, Ye Dan, Lin Chang-Ching, Uemoto Yasuaki, Liao Jiemin, Wegrzyn Claire, Walko Christine M, Ryan Lianne Y, Keenan Jennifer C, Medford Arielle J, Liu Shiyuan A, Wulf Gerburg M, Clifton Katherine K, Ma Cynthia X, Han Hyo S, Zhang Nicole, Ellisen Leif W, Bardia Aditya, Arteaga Carlos L, Hanker Ariella B, Wander Seth A

A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2

一项针对携带 ATM、BRCA1、BRCA2、PALB2 和 CHEK2 致病性变异的晚期胰腺癌患者的 Niraparib II 期试验

Huffman, Brandon M; Diossy, Miklos; Yurgelun, Matthew B; Horick, Nora; Li, Yvonne Y; Crowdis, Jett; Nguyen, Huy; Parmar, Kalindi; Kochupurakkal, Bose S; Vonk, Leonard; Lam, Helen; Ramsey, Kaitlyn; Andrews, Elizabeth; Loeb, Sarah C; Culnane, Leigh; Biller, Leah H; Bullock, Andrea J; Enzinger, Andrea; Giannakis, Marios; Jackson, Nadine A; Ng, Kimmie; Nowak, Jonathan A; Patel, Anuj K; Perez, Kimberly J; Rattani, Ahmed; Rubinson, Douglas A; Schlechter, Benjamin L; Singh, Harshabad; Cai, Mingyang; Raghavan, Srivatsan; Clark, Jefferey W; Peters, Mary Linton; Weipert, Caroline M; Wolpin, Brian M; D'Andrea, Alan D; Shapiro, Geoffrey I; Aguirre, Andrew J; Szallasi, Zoltan; Cleary, James M

ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

胰腺导管腺癌患者循环游离DNA中ERBB2(HER2)扩增和共存的KRAS改变与HER2抑制剂疗效的关系

Barzi, Afsaneh; Weipert, Caroline M; Espenschied, Carin R; Raymond, Victoria M; Wang-Gillam, Andrea; Nezami, Mohammad Amin; Gordon, Eva J; Mahadevan, Daruka; Mody, Kabir

Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma

晚期肝细胞癌血液肿瘤突变负荷的特征和预测因子

Franses, Joseph W; Lim, Mir; Burgoyne, Adam M; Mody, Kabir; Lennerz, Jochen; Chang, Jeremy; Imperial, Robin; Dybel, Stacey N; Dinh, Thi M; Masannat, Jude; Weipert, Caroline M; Hsiehchen, David

Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)

厄洛替尼和奥那司匹布乳酸盐靶向EGFR 20号外显子插入非小细胞肺癌(NSCLC):加州癌症联盟I/II期试验(NCI 9878)

Riess, Jonathan W; Reckamp, Karen L; Frankel, Paul; Longmate, Jeffrey; Kelly, Karen A; Gandara, David R; Weipert, Caroline M; Raymond, Victoria M; Keer, Harold N; Mack, Philip C; Newman, Edward M; Lara, Primo N Jr

Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis

通过循环肿瘤DNA分析确定晚期非小细胞肺癌患者靶向治疗的持续时间

Reckamp, Karen L; Patil, Tejas; Kirtane, Kedar; Rich, Thereasa A; Espenschied, Carin R; Weipert, Caroline M; Raymond, Victoria M; Santana-Davila, Rafael; Doebele, Robert C; Baik, Christina S

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma

恶性间皮瘤中癌症易感基因种系突变的频率

Panou, Vasiliki; Gadiraju, Meghana; Wolin, Arthur; Weipert, Caroline M; Skarda, Emily; Husain, Aliya N; Patel, Jyoti D; Rose, Buerkley; Zhang, Shannon R; Weatherly, Madison; Nelakuditi, Viswateja; Knight Johnson, Amy; Helgeson, Maria; Fischer, David; Desai, Arpita; Sulai, Nanna; Ritterhouse, Lauren; Røe, Oluf D; Turaga, Kiran K; Huo, Dezheng; Segal, Jeremy; Kadri, Sabah; Li, Zejuan; Kindler, Hedy L; Churpek, Jane E

Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk

多基因检测中致病性 ATM 和 CHEK2 变异的临床解读:应对中等风险

West, Allison H; Blazer, Kathleen R; Stoll, Jessica; Jones, Matthew; Weipert, Caroline M; Nielsen, Sarah M; Kupfer, Sonia S; Weitzel, Jeffrey N; Olopade, Olufunmilayo I